Samantha completed her PhD at the National Drug and Alcohol Research Centre, UNSW in Sydney. Her thesis was concerned with physical and mental health harms that disproportionately implicate people who inject drugs and strategies that may prevent these harms from occurring.
She has collaborated with global agencies, such as the United Nations Office on Drugs and Crime, the World Health Organization, and the Global Burden of Disease project, in improving global estimates of injecting drug use and associated harm. She is currently posted at the National Drug Research Institute (NDRI) Melbourne where she will be working to expand on our understanding of injecting-related infections and evaluating harm reduction services.
Drug and Alcohol Review
Zachary Lloyd, Samantha Colledge‐Frisby, Nicholas Taylor, Michael Livingston, Amanda Roxburgh, Zachary Lloyd, Samantha Colledge‐Frisby, Nicholas Taylor, Michael Livingston, Amanda Roxburgh
Drug and Alcohol Review
Zachary Lloyd, Samantha Colledge‐Frisby, Nicholas Taylor, Michael Livingston, Amanda Roxburgh, Zachary Lloyd, Samantha Colledge‐Frisby, Nicholas Taylor, Michael Livingston, Amanda Roxburgh
The Medical Journal of Australia
Rebecca Winter, Farah Houdroge, Samantha Colledge‐Frisby, Mark Stoové, Nick Scott, Farah Houdroge, Samantha Colledge‐Frisby, Rebecca Winter, Mark Stoové, Nick Scott
The VMAX cohort study follows 850 people who use methamphetamine recruited from metropolitan Melbourne and 3 regions of rural Victoria.
The largest and longest-running active cohort study of people who inject drugs in Australia (since 2008).